Safety and efficacy of fimasartan with essential hypertension patients in real world clinical practice: data from a post marketing surveillance in Korea

The safety and efficacy of fimasartan have been evaluated through post-marketing surveillance in real world clinical practice. The multi-center, prospective, open-label and non-interventional study. A total of 3,945 patients (3,729 patients for safety assessment and 3,473 patients for efficacy asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Su-Eun, Jeong, Seung Hee, Kang, Hye Jeong, Hong, Myung Sook, Paek, Eunah, Cho, Hijung, Choe, Seong Choon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2018
Materias:
PMS Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989236/
https://www.ncbi.nlm.nih.gov/pubmed/32055561
http://dx.doi.org/10.12793/tcp.2018.26.3.118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989236/
https://www.ncbi.nlm.nih.gov/pubmed/32055561
http://dx.doi.org/10.12793/tcp.2018.26.3.118

Ejemplares similares